Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

1,006.30INR
3:58pm IST
Change (% chg)

Rs63.25 (+6.71%)
Prev Close
Rs943.05
Open
Rs946.90
Day's High
Rs1,035.95
Day's Low
Rs937.80
Volume
7,567,230
Avg. Vol
1,843,924
52-wk High
Rs1,035.95
52-wk Low
Rs552.55

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Ltd. (Sun) is an international pharmaceutical company. The Company manufactures and markets a variety of pharmaceutical formulations as branded generics, as well as generics in the United States, India and several other global markets. It operates through four segments, including US Generics, Indian... (more)

Overall

Beta: 0.57
Market Cap(Mil.): Rs1,953,211.00
Shares Outstanding(Mil.): 2,071.16
Dividend: 1.50
Yield (%): 0.16

Financials

  SUN.NS Industry Sector
P/E (TTM): 32.94 39.75 40.37
EPS (TTM): 28.63 -- --
ROI: -- 16.86 16.19
ROE: -- 17.37 17.14
Search Stocks

Sun Pharma to buy Glaxo's opiates business in Australia

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

03 Mar 2015

CORRECTED-BUZZ-India's Suzlon rises to daily upper limit on turnaround hopes

** Suzlon Energy shares jump as much as 20 pct to daily upper limit

18 Feb 2015

Sun Pharma third-quarter profit falls

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Saturday third-quarter net profit fell unexpectedly due to a decline in sales in the United States and costs from resolving regulatory issues at a manufacturing plant.

14 Feb 2015

BUZZ-India's Suzlon gains on talk of investment by Sun Pharma founder

** Traders cite persistent speculation that billionaire and Sun Pharmaceutical Industries Ltd's founder Dilip Shanghvi is looking to invest in the company in a personal capacity

12 Feb 2015

Deals of the day- Mergers and acquisitions

Jan 30 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

31 Jan 2015

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

31 Jan 2015

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

31 Jan 2015

UPDATE 1-Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

31 Jan 2015

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 - Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sells its interest in a generic anti-bacterial medicine, the Federal Trade Commission said on Friday.

31 Jan 2015

BUZZ-JPMorgan upgrades India's Sun Pharma to "overweight"

** JPMorgan upgrades Sun Pharmaceutical Industries Ltd to "overweight" from "neutral"

06 Jan 2015

Earnings vs. Estimates

Search Stocks